Letter regarding Wen X.Y. et al. entitled "matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: A meta-analysis"

Tumor Biology

Volumn 35, Issue 5, 2014, Pages 5053-

  Guo, Hong Bin ^a   Xiao, Tao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A;

CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; EDITORIAL; HUMAN; META ANALYSIS (TOPIC); OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAMPLE SIZE; SYSTEMATIC REVIEW (TOPIC); BONE TUMOR; GENETICS; MORTALITY; NOTE;

BONE NEOPLASMS; HUMANS; MATRIX METALLOPROTEINASE 2; OSTEOSARCOMA;

EID: 84902968274     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1658-x     Document Type: Editorial

References (6)

1. Wen X, Liu H, Yu K, Liu Y. Matrixmetalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis. Tumour Biol. 2013. doi:10.1007/s13277-013-1116-1.
2. Uchibori M, Nishida Y, Nagasaka T, Yamada Y, Nakanishi K, Ishiguro N. Increased expression ofmembrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma. Int J Oncol. 2006;28:33-42.
3. Li W, Ye Z, Yang D, Tao H. The expression of vascular endothelial growth factor, matrix metalloproteinases 2,9 in osteosarcoma [article in Chinese]. Zhejiang Med J. 2006;28:691-4.
4. Kushlinsky NE, Solovyov YN, Babkina IV, Gershtein ES, Bulicheva IV. Matrix metalloproteinases 2,7, and tissue inhibitor of matrix metalloproteinase-1 in the sera of patients with bone tumors. Bull Exp Biol Med. 2010;149:233-5.
5. Sun C, Zang Y, Yang L, Liu H, Li S. Association of malignant osteoblastoma prognosis with midkine, survivin and MMP-2 expression [article in Chinese]. Med Recapitulate. 2010;16:3833-4.
6. Xu J, Shi X, Wu S, Zhang X, Zhou Z. Expression and clinical significance of reck and MMP-2 in osteosarcoma [article in Chinese]. Chin Clin Oncol. 2010;15:222-5.